Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-037389
Filing Date
2024-08-15
Accepted
2024-08-15 16:10:50
Documents
103
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K alvo-20240630_d2.htm   iXBRL 6-K 24170
2 EX-99.1 alvo-20240630.htm   iXBRL EX-99.1 972273
3 EX-99.2 alvotechq22024-mda.htm EX-99.2 245178
4 EX-99.3 earningsreleaseq22024notab.htm EX-99.3 62481
10 image_0.jpg GRAPHIC 20436
  Complete submission text file 0001628280-24-037389.txt   7503466

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alvo-20240630.xsd EX-101.SCH 90577
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alvo-20240630_cal.xml EX-101.CAL 83636
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alvo-20240630_def.xml EX-101.DEF 317881
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alvo-20240630_lab.xml EX-101.LAB 703401
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alvo-20240630_pre.xml EX-101.PRE 528451
105 EXTRACTED XBRL INSTANCE DOCUMENT alvo-20240630_d2_htm.xml XML 1076018
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

EIN.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41421 | Film No.: 241212532
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)